Federal Register / Vol. 72, No. 210 / Wednesday, October 31, 2007 / Notices 61661 

Dated: October 24, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5393 Filed 10–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors, National 

Institute of Mental Health. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Mental Health, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Institute of Mental 

Health. 

Date: November 27–28, 2007. 

Time: November 27, 2007, 7 p.m. to 10 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Hilton Washington DC/Rockville 

Meeting Center, 1750 Rockville Pike, 

Rockville, MD 20852. 

Time: November 28, 2007, 8:30 a.m. to 1 

p.m. 

Agenda: To review and evaluate the 

Section on Directed Gene Transfer, Section 

on Neurocircuitry, Section on Functional 

Imaging Methods, and Section on Cognitive 

Neuropsychology. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C, Rockville, 

MD 20852. 

Time: November 28, 2007, 1:30 p.m. to 

2:30 p.m. 

Agenda: To review and evaluate the 

Training Fellows and Staff Scientists. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C, Rockville, 

MD 20852. 

Time: November 28, 2007, 2:30 p.m. to 

5:30 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C, Rockville, 

MD 20852. 

Contact Person: Richard K. Nakamura, 

PhD, Acting Scientific Director, Division of 

Intramural Research Programs, National 

Institutes of Mental Health, NIH, 10 Center 

Drive, Room 4N222, MSC 1381, Bethesda, 

MD 20892–1381, 301–496–4183, 

rnakamur@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: October 24, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5394 Filed 10–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, The Central Medulla 

and the Sudden Infant Death Syndrome. 

Date: November 16, 2007. 

Time: 1:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, 5B01, Rockville, MD 

20852, (Telephone Conference Call). 

Contact Person: Gopal M. Bhatnagar, PhD, 

Scientific Review Administrator, National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6100 Bldg Rm 5B01, Rockville, MD 20852, 

(301) 435–6889, bhatnagg@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: October 24, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5395 Filed 10–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of Biotechnology Activities; 

Recombinant DNA Research: Action 

Under the NIH Guidelines for Research 

Involving Recombinant DNA Molecules 

(NIH Guidelines) 

AGENCY: National Institutes of Health 

(NIH), PHS, DHHS. 

ACTION: Notice of final action under the 

NIH Guidelines. 

SUMMARY: Specific proposals to conduct 

research involving the deliberate 

transfer of a drug resistance trait to a 

microorganism that causes disease in 

humans have been reviewed by the 

Recombinant DNA Advisory Committee 

(RAC) and approved by the NIH 

Director. Approval of these experiments 

constitutes a Major Action under section 

III–A–1 of the NIH Guidelines. 

DATES: This final action is effective 

September 24, 2007. 

FOR FURTHER INFORMATION: Background 

documentation and additional 

information can be obtained from the 

Office of Biotechnology Activities 

(OBA), National Institutes of Health, 

6705 Rockledge Drive, Suite 750, MSC 

7958, Bethesda, Maryland 20892–7958; 

e-mail at oba@od.nih.gov, or telephone 

at 301–496–9838. The NIH/OBA Web 

site is located at: http:// 

www4.od.nih.gov/oba/. 

SUPPLEMENTARY INFORMATION: This final 

action allows Dr. Dan Rockey and Dr. 

Walter Stamm (at Oregon State 

University and the University of 

Washington, respectively) to 

deliberately transfer a gene encoding 

tetracycline resistance from Chlamydia 

suis (a swine pathogen) into C. 

trachomatis (a human pathogen). This 

approval is specific to Drs. Rockey and 

Stamm and research with these resistant 

organisms may only occur under the 

conditions outlined below. It should be 


rwilkins on PROD1PC63 with NOTICES